跳至主要内容
临床试验/NCT07211399
NCT07211399撤回1 期

The Role of Intraoperative Opioids in the Transition From Acute to Chronic Opioid Use and Chronic Pain

Jacques E. Chelly1 个研究点 分布在 1 个国家目标入组 700 人开始时间: 2026年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
撤回
发起方
入组人数
700
试验地点
1
主要终点
PACU Opioid Medication Administered

研究概览

简要总结

In the current opioid crisis, the use of opioids as the main pain management method is recognized as a consistent risk factor for chronic opioid use and the development of Opioid Use Disorder (OUD), as well as related complications like overdose fatalities among surgical patients. The most recent data suggests that 3.1%-10.5% of surgical patients are at risk of developing OUD. On average, there are over 40 million major surgeries that require post-op pain management, taking place in the United States each year. This puts over 1 million American surgical patients at risk for opioid dependency and misuse.

This is a prospective randomized controlled intervention study that will examine the physical and emotional outcomes of surgical patients who receive intraoperative Opioid-Free Anesthesia (OFA) supplemented with Non-Opioid Analgesia (NOAs), and how this relates to surgical patients who receive intraoperative Opioid-Based Anesthesia (OBA).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •≥18 years old
  • •scheduled for an elective, unilateral Total Knee Arthroplasty (TKA)
  • •anticipated to stay in PACU after surgery
  • •receiving general anesthesia (i.e. fentanyl, etc.)
  • •receiving spinal regional anesthesia

排除标准

  • •<18 years of age
  • •sent to the ICU at any point during their hospital stay
  • •scheduled for a bilateral TKA
  • •received intraoperative opioids other than fentanyl
  • •received patient-controlled analgesia in PACU

研究组 & 干预措施

Opioid-based anesthesia (OBA) Group

Active Comparator

Subjects enrolled in this arm will receive IV-acetaminophen, IV-lidocaine, and fentanyl prior to intubation.

干预措施: Opioid-based anesthesia (Drug)

Opioid-free anesthesia (OFA) Group

Experimental

Subjects enrolled in this arm will receive IV-acetaminophen, IV-lidocaine, dexmedetomidine, and ketamine prior to intubation.

干预措施: Opioid-free anesthesia (Drug)

结局指标

主要结局

PACU Opioid Medication Administered

时间窗: Postoperative Day 5

Medications will be extracted from the electronic medical records. Opioid-based medications will be reported as mean(SD).

PACU Non-Opioid Medication Administered

时间窗: Postoperative Day 5

Medications will be extracted from the electronic medical records.Non-opioid-based medications will be reported as mean(SD).

PACU NRS Pain Score at Rest

时间窗: Postoperative Day 5

Numerical Rating Scale (NRS) Pain Scores will be self reported on a scale of 0-10, 0 being no pain at all, 10 being worst pain imaginable. Pain scores at rest will be averaged and reported as mean(SD).

PACU NRS Pain Score with Movement

时间窗: Postoperative Day 5

Numerical Rating Scale (NRS) Pain Scores will be self reported on a scale of 0-10, 0 being no pain at all, 10 being worst pain imaginable. Pain scores with movement will be averaged and reported as mean(SD).

次要结局

未报告次要终点

研究者

发起方
Jacques E. Chelly
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jacques E. Chelly

Professor

University of Pittsburgh

研究点 (1)

Loading locations...

相似试验